Closed · CDC-RFA-PS23-0013 · CFDA 93.939 · Discretionary

Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States

Federal grant opportunity posted by Centers for Disease Control - NCHHSTP, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 6, 2023
Close date
1
Expected awards

The verdict

Assuring Comprehensive Perinatal, Maternal and Infant Health and the Elimination of Perinatal HIV in the United States is a closed discretionary listing from Centers for Disease Control - NCHHSTP that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 100 other opportunities from Centers for Disease Control - NCHHSTP.

Varies
award range
Closed
application status
1
expected award
93.939
CFDA program

Archived opportunity record

Assuring Comprehensive Perinatal is closed (last close June 6, 2023). Check the agency catalog for replacement NOFOs. Centers for Disease Control - NCHHSTP still indexes 100 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 6, 2023

Posted Apr 5 Closes Jun 6

Est. Total Funding

$3,750,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The NOFO supports program activities to achieve and maintain the elimination of perinatal HIV transmission in the United States and to optimize the health and wellbeing of people with HIV, their infants, and all persons with perinatally acquired HIV. The recipient will collaborate with CDC over a 5 year period of performance to establish a National Resource Center for the implementation of CDC’s Framework for the Elimination of Perinatal HIV in the United States and will convene a Task Force of subject matter experts from public health, clinical care and persons living with HIV to develop innovative approaches to optimize perinatal, maternal/parental and infant health for persons affected by HIV. The recipient will also disseminate resources and technical assistance through large educational and best-practice-sharing networks. These activities will result in an increased awareness by clinical and public health professionals of strategies to achieve and maintain elimination of perinatal HIV in the United States as well as approaches to optimize the health of families affected by HIV. The provision of technical assistance and capacity building to improve perinatal HIV care and prevention systems will also create opportunities to utilize aspects of The Framework for the prevention of congenital syphilis or other perinatal infections.In 2012, CDC published a framework for the elimination of perinatal HIV transmission in the United States (The Framework). Based on the latest national data, elimination of perinatal HIV transmission may have occurred in the United States: in 2019, CDC received 32 reports of U.S.-born infants with diagnosed perinatal infection. To maintain low numbers of diagnoses of perinatal HIV each year, and to ensure the short- and long-term safety of perinatal HIV prevention interventions, it will be necessary to build upon past work to implement The Framework. The 6 components of The Framework include: 1) reproductive health, family planning and prepregnancy care services for women of childbearing age with HIV, 2) HIV testing and comprehensive case-finding by public health, 3) assurance of clinical care and behavioral health services for pregnant women with HIV and their infants, 4) continuous quality improvement of local perinatal HIV health systems through a case review and community action process such as the FIMR-HIV methodology, 5) research and long-term monitoring to ensure preventive interventions and contemporary antiretroviral medications are not only efficacious but also safe, and 6) thorough HIV data surveillance to evaluate and direct public health prevention programs.In a previous CDC-funded activity, PS17-1712, an Elimination of Perinatal HIV Task Force comprised of clinical and public health subject matter experts as well as women with HIV identified key issues necessary to maintain gains in perinatal prevention and to optimize the health and wellbeing of women with HIV and their children. Acquisition of HIV during pregnancy from male partners was identified as an ongoing concern, and strategies such as partner HIV testing during pregnancy are needed not only to prevent transmission to pregnant women and children, but also to provide HIV treatment for the health of partners. New strategies to ensure that HIV treatment and preventive interventions are not only effective, but also safe during conception, throughout pregnancy and lactation are needed. In addition, up-to-date, comprehensive, and timely surveillance systems are needed for continuous and vigilant monitoring of the long-term safety of prenatal and early-life antiretroviral exposure. Women with HIV in the United States are increasingly expressing desires to breastfeed their infants, and recommendations in the United States regarding infant feeding for people with HIV are evolving. Developing and disseminating information to support women with HIV and their providers is needed to ensure infant feeding approaches optimize infant and maternal health.As considerations of perinatal HIV transmission evolve in this era, it will be necessary to maintain a public health and clinical workforce capable of dealing with the many issues. This NOFO will support activities that contribute to maintaining the gains in perinatal HIV prevention and perhaps further reduce the annual number of perinatal HIV infections. It also will contribute to improvements in maternal, paternal and child health along the HIV prevention and care continuums.If additional funds become available, this NOFO will provide opportunities to share infrastructure and resources with health care providers and public health professionals to utilize similar approaches to reduce other congenital or perinatal infections, including congenital syphilis, in the United States.

Wide-open applicant board · 13 Grants.gov doors

Assuring Comprehensive Perinatal prints 13 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +9 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). Inside Centers for Disease Control - NCHHSTP's indexed book this exact eligibility-code string is unique to this listing.

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 25
Others (see official listing text)
Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Margaret A. Lampe, Project Officer MLampe@cdc.gov

What to do next

Assuring Comprehensive Perinatal is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 93.939 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants